Cornerstone Investment Partners LLC Has $75.71 Million Holdings in McKesson Corporation $MCK

Cornerstone Investment Partners LLC boosted its position in shares of McKesson Corporation (NYSE:MCK) by 0.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,004 shares of the company’s stock after acquiring an additional 585 shares during the period. McKesson accounts for 3.2% of Cornerstone Investment Partners LLC’s investment portfolio, making the stock its 14th biggest holding. Cornerstone Investment Partners LLC’s holdings in McKesson were worth $75,712,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in MCK. Brighton Jones LLC grew its holdings in McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of McKesson in the 1st quarter valued at $233,000. Sivia Capital Partners LLC lifted its stake in McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after purchasing an additional 300 shares during the period. Concurrent Investment Advisors LLC lifted its position in shares of McKesson by 11.9% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 1,987 shares of the company’s stock worth $1,456,000 after buying an additional 211 shares during the period. Finally, CWM LLC boosted its stake in shares of McKesson by 5.7% in the 2nd quarter. CWM LLC now owns 14,614 shares of the company’s stock valued at $10,709,000 after purchasing an additional 792 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. 0.08% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on MCK shares. Barclays began coverage on McKesson in a report on Monday, December 8th. They set an “overweight” rating and a $960.00 target price on the stock. Mizuho lifted their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. TD Cowen lifted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, Robert W. Baird set a $968.00 price target on shares of McKesson in a research note on Wednesday, January 14th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $937.07.

McKesson Price Performance

McKesson stock opened at $951.91 on Thursday. McKesson Corporation has a fifty-two week low of $585.22 and a fifty-two week high of $971.93. The firm has a market capitalization of $116.60 billion, a price-to-earnings ratio of 27.38, a PEG ratio of 1.51 and a beta of 0.40. The company’s 50 day simple moving average is $835.56 and its 200 day simple moving average is $785.04.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period last year, the firm posted $8.03 earnings per share. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.